Summary of Consolidated Financial Statements for the Nine Months Ended September 30, 2022
(Japanese GAAP)
Company name
Listing code
Representative
Contact

November 11, 2022
HORIBA, Ltd.
Listed stock exchanges: Tokyo
6856
URL: https://www.horiba.com/int/
Atsushi Horiba, Chairman & Group CEO
TEL: (81)75-313-8121
Yoshihiro Morita, Department Manager, Finance and Accounting Dept.

(Figures have been rounded down to the nearest million yen)

1. Consolidated Results for the Nine Months Ended September 30, 2022 (January 1, 2022 - September 30, 2022)(Percentages represent changes from the corresponding in the previous year)(1) Consolidated Operating Results
Net Sales
Millions of yen

Nine Months Ended 9/30/22
Nine Months Ended 9/30/21

185,121
153,957(Note) Comprehensive income: FY2022Q3

Nine Months Ended 9/30/22
Nine Months Ended 9/30/21

Operating Income％ Millions of yen
20.2
28,571
18.6
19,859Ordinary Income％ Millions of yen
43.9
29,50881.1
19,86835,534 million yen (75.2％)

％
48.5
84.0

FY2021Q3

Net Income Attributableto Owners of Parent
Millions of yen

20,702
13,721

％
50.9
82.3

20,278 million yen (366.1％)

Net Income Attributable
Net Income Attributableto Owners of Parent per Shareto Owners of Parent per Share(Diluted)
Yen
Yen
490.40487.86325.17323.51(2) Consolidated Financial Position
Total Assets

Shareholders'Equity Ratio

Net Assets

Millions of yen
Millions of yen％
As of 9/30/22
402,314233,231
57.8
As of 12/31/21
371,585
204,493
54.8(Reference) Net assets excluding subscription rights to shares and non-controlling interests:
As of 9/30/22
232,456 million yen
As of 12/31/21 203,688 million yen

2. Dividends
Dividend per ShareFY 12/2021

First
QuarterYen-

FY 12/2022-

SecondQuarter
Yen
50.00

Third
Quarter
Yen
-

65.00

FY 12/2022 (Forecasts)(Note) Changes in the latest dividend forecasts released:

Year End

Total

Yen
100.00Yen
150.00145.00210.00-Yes

3. Consolidated Forecasts for the Year Ending December 31, 2022 (January 1, 2022 - December 31, 2022)(Percentages represent changes from the previous fiscal year)

Net Sales

Operating Income

Ordinary Income％ Millions of yen％ Millions of yen
Full Year
265,000 18.1
43,000 34.2
43,500(Note) Changes in the latest business forecasts released: Yes
Millions of yen

1

％
35.8

Net Income Attributableto Owners of Parent
Millions of yen

30,000％40.8

Net Income Attributableto Owners of Parent
per Share
Yen
710.40HORIBA, Ltd. (Consolidated)

Notes(1) Changes in significant subsidiaries during the period(Changes in specified subsidiaries that caused a change in the scope of consolidation):

None(2)Application of the accounting method specific to quarterly consolidated financial statements:

Yes(3) Changes in accounting policies, accounting estimates and retrospective restatement① Changes in accounting policies associated with revision of accounting standards: Yes② Changes in accounting policies arising from other than the above: None
③ Changes in accounting estimates: None
④ Retrospective restatement: None
(4) Number of shares outstanding (common stock)① Shares issued (including treasury stock)
September 30, 2022 42,532,752② Treasury stock
September 30, 2022
303,053③ Average number of outstanding sharesJan. - Sep., 2022

42,214,607

December 31, 2021

42,532,752

December 31, 2021

335,502

Jan. - Sep., 2021

42,197,319

Note 1. This consolidated financial report is not subject to quarterly review by certified public accountants or accounting
firms.
Note 2. Appropriate use of business forecasts and other important information
The forecasts of dividend amount and business performance contained in this report have been made based on
certain future assumptions, outlooks, and plans which are available at the HORIBA Group as of November 11,
2022. However, due to risks and various uncertain factors such as future business operation policies, changes inthe economic environment in Japan and overseas, fluctuation of currency rates, it is possible that actual
performance would vary considerably from the forecasts.

2

HORIBA, Ltd. (Consolidated)1. Qualitative Information Concerning Consolidated Results(1) Information Concerning Consolidated Operating Results(For details, see page 11-13, “3. Supplemental Information - HORIBA, Ltd. Financial Highlights for the Nine Months
Ended September 30, 2022”)

During the nine months ended September 30, 2022, HORIBA, Ltd. (“the Company”) and its consolidated subsidiaries(together “the HORIBA Group” or “HORIBA” as a consolidated group) increased sales by 20.2% year-on-year to
185,121 million yen, mainly due to an increase in sales of the Semiconductor segment. Operating income increased by
43.9% to 28,571 million yen, ordinary income by 48.5% to 29,508 million yen and net income attributable to owners ofparent (“net income”) by 50.9% to 20,702 million yen.
The operating results of each business segment are summarized as follows.

(Automotive Segment)
Mainly due to an increase in sales of the ECT (Engineering Consultancy & Testing) business in Europe, segment
sales increased by 10.7% year-on-year to 41,320 million yen. On the profit side, operating loss of 3,292 million yen
was recorded owing mainly to rising purchasing prices, an increase in expenses due to expanded investment ingrowth area, as well as impact of exchange rate fluctuations (compared to an operating loss of 1,935 million yen in
the first nine months of the previous year).

(Process & Environmental Segment)
Mainly due to an increase in sales in Americas and Japan, segment sales increased by 5.9% year-on-year to 15,425
million yen. On the profit side, operating income however decreased by 24.2% to 981 million yen owing mainly toincrease in procurement/purchasing cost.

(Medical-Diagnostics Segment)
Mainly due to an increase in sales in Asia and Japan, segment sales increased by 12.9% year-on-year to 21,588
million yen. On the profit side, operating loss of 21 million yen was recorded owing mainly to an increase inprocurement/purchasing cost, even though the sales of reagents, which are profitable products, increased (compared
to an operating income of 84 million yen in the first nine months of the previous year).

(Semiconductor Segment)
Sales to semiconductor production equipment manufacturers increased significantly, in response to expansion ofsemiconductor manufacturers’ capital expenditures. As a result, segment sales increased by 29.9% year-on-year to81,416 million yen and operating income increased by 48.3% to 29,248 million yen.

(Scientific Segment)
Sales of Raman spectrometers and optical components increased. As a result, segment sales increased by 25.2%
year-on-year to 25,370 million yen and operating income increased by 139.1% to 1,655 million yen.

3

HORIBA, Ltd. (Consolidated)(2) Information Concerning Consolidated Earnings Forecasts for FY2022
HORIBA’s full year consolidated earnings forecasts are as follows.
Our assumption for the exchange rate has been changed from 130 yen to 133 yen against the US dollars and 135 yen
to 138 yen against the euro.
Consolidated forecasts of FY2022 (Full year)
Amount : Millions of yen
Previous Forecasts(As of Aug. 12)

Revised Forecasts(As of Nov. 11)

Changes

Net Sales

260,000

265,000+5,000Operating Income

40,00043,000+3,000Ordinary Income

40,00043,500+3,500Net Income Attributableto Owners of Parent

28,00030,000+2,000Consolidated forecasts of FY2022 by segment (Full year)
Net Sales

Amount : Millions of yen Operating Income
Previous
Revised
Forecasts Forecasts
Changes(As of Aug. (As of Nov.
12)
11)

Amount : Millions of yen
Previous
Revised
Forecasts Forecasts
Changes(As of Aug. (As of Nov.
12)
11)

Automotive

66,00066,000-Automotive-(1,500)-1,500

Process &Environmental

23,50023,500-

Process &Environmental

2,000

2,000

-

Medical-Diagnostics

28,50028,500-

Medical-Diagnostics

500

500

-

Semiconductor

107,000

112,000+5,000

Semiconductor

35,00039,500+4,500Scientific35,00035,000-Scientific

2,500

2,500

-

Total

260,000

265,000+5,000Total

40,00043,000+3,000

The Company has revised downward its forecast for operating income of the Automotive Segment by 1,500 million
yen, reflecting the expected impact of a temporary increase of expenses in response to boosting orders, and risingpurchasing prices. Meanwhile, forecasts for sales and operating income of the Semiconductor Segment have beenrevised upward by 5,000 million yen and 4,500 million yen respectively by taking into account recent order andexchange rate trends.
As a result, the overall sales forecast has been revised upward by 5,000 million yen to 265,000 million yen and theoperating income forecast has also been revised upward by 3,000 million yen to 43,000 million yen. Due to theincrease in operating income and other items, the forecast for ordinary income has been revised upward by 3,500
million yen to 43,500 million yen, and the forecast for net income, by 2,000 million yen to 30,000 million yen.

4

HORIBA, Ltd. (Consolidated)Amendments to dividend forecasts for FY2022
Annual Dividend per Share(Yen)Record Date

InterimYear-end

Previous Forecasts(As of Aug. 12)
Revised Forecasts
Result for FY2022

65(Reference)
Results for FY2021

50

Total
135

200

145

210

100

150

The Company’s shareholder return policy is to set the total returns to shareholders (the combined amount of dividend
payments and share buybacks) at approximately 30% of consolidated net income.
The dividend forecast for FY2022 had been 200 yen per share since the announcement of the “Summary ofConsolidated Financial Statements for the Six Months Ended June 30, 2022” on August 12, 2022. However,considering the revised consolidated earnings forecasts for FY2022, the Company has amended the forecast for the
year-end per-share dividend with an increase of 10 yen to 145 yen and thus revised upward the annual dividend
forecast to 210 yen, including 65 yen which had already been paid.

Cautionary statement with respect to earnings forecasts
The forecasts of dividend amount and business performance contained in this report have been made based on
certain future assumptions, outlooks, and plans which are available at the HORIBA Group as of November 11, 2022.
However, due to risks and various uncertain factors such as future business operation policies, changes in theeconomic environment in Japan and overseas, fluctuation of currency rates, it is possible that actual performance
would vary considerably from the forecasts.

5

HORIBA, Ltd. (Consolidated)2. Consolidated Financial Statements and Notes(1) Consolidated Balance Sheets
Amount : Millions of yen
FY2021

FY2022 Third Quarter(As of December 31, 2021)(As of September 30, 2022)

Cash and bank deposits

135,023

132,244

Trade notes and accounts receivable

59,877--

61,155Marketable securities

2,012

1,054

Merchandise and finished goods

17,86424,914Work in process

16,51325,781

Raw materials and supplies

18,736

26,688Other current assets

9,249

12,860Allowance for doubtful accounts(1,232)(1,303)

Total Current Assets

258,044283,396

Buildings and structures, net

45,64853,612

Machinery, equipment and vehicles, net

12,986

14,177Land

15,99417,301

Construction in progress

9,231

5,277

Other property, plant and equipment, net

4,441

4,407

Total Property, Plant and Equipment

88,302

94,774

Goodwill

966

731

Software

1,968

1,695

Leasehold interests in land

607

676

Other intangibles

881

924

Total Intangibles

4,423

4,028

12,487

10,231

387

525

Deferred tax assets

5,002

6,597

Other investments and other assets

2,979

2,802

(43)

(40)

20,814

20,115

113,540

118,918

371,585

402,314

AssetsCurrent Assets:

Notes and accounts receivable - trade,and contract assets

Fixed Assets:
Property, Plant and Equipment:

Intangibles:

Investments and Other Non-Current Assets:
Investment securities
Retirement benefit asset

Allowance for doubtful accounts
Total Investments and Other Non-Current Assets
Total Fixed Assets
Total Assets

6

HORIBA, Ltd. (Consolidated)Amount : Millions of yen
FY2021

FY2022 Third Quarter(As of December 31, 2021)(As of September 30, 2022)

Trade notes and accounts payable

29,54633,674

Short-term loans payable

25,107

11,921

Accounts payable-other

16,407

17,396

Accrued income taxes

7,632

6,457

Advances received

14,308-Contract liabilities-

23,051

1,137

2,570

-

659

Reserve for product warranty

2,630

2,787

Other current liabilities

5,368

5,619

Total Current Liabilities

102,139

104,138

Corporate bonds

30,00030,000Long-term loans payable

25,07725,360

Deferred tax liabilities

1,731

1,223

Retirement benefit liability

2,107

2,325

Other non-current liabilities

6,036

6,036

Total Non-Current Liabilities

64,95364,944

167,092

169,083

12,011

12,011

Capital surplus

18,624

18,684Retained earnings

166,892

180,630

Treasury stock(1,323)(1,195)

Total Shareholders' Equity

196,204

210,129

Net unrealized holding gains or losses on securities

5,664

4,094

Foreign currency translation adjustments

1,889

18,297

Remeasurements of defined benefit plans

(69)

(65)

7,484

22,326

791

771

12

3

Total Net Assets

204,493

233,231

Total Liabilities and Net Assets

371,585

402,314

Liabilities
Current Liabilities:

Accrued bonuses to employees
Accrued bonuses to directors and corporate auditors

Non-Current Liabilities:

Total Liabilities
Net Assets
Shareholders' Equity
Common stock

Accumulated Other Comprehensive Income

Total Accumulated Other Comprehensive Income
Subscription Rights to Shares
Non-Controlling Interests

7

HORIBA, Ltd. (Consolidated)(2) Consolidated Statements of Income and Consolidated Comprehensive Income Statements(Consolidated Statements of Income)Amount : Millions of yen
FY2021 Third Quarter(Nine Months Ended
September 30, 2021)

FY2022 Third Quarter(Nine Months Ended
September 30, 2022)

Net Sales

153,957

185,121

Cost of Sales

89,252

106,113Gross Income

64,70479,007

Selling, General and Administrative Expenses

44,84550,435

Operating Income

19,85928,571

Interest income

143

315

Dividend income

119

158

-

568

Subsidy income

69

102

Other

279

330

Total Non-Operating Income

610

1,475

Interest expenses

364

457

Foreign exchange losses

169

-

Other

67

81

Total Non-Operating Expenses

601

539

19,86829,508Gain on sales of fixed assets

15

494

Gain on sales of investment securities

6

20

Gain on reversal of share acquisition rights

-

1

22

516

Loss on sales of fixed assets

20Loss on disposal of fixed assets

60

106

-

0

Total Extraordinary Losses

63

106

Income before Income Taxes

19,827

29,918

Income taxes (current)

6,406

10,295

Income taxes (deferred)(297)(1,066)

Total Income Taxes

6,109

9,228

13,71820,689(2)(12)

13,721

20,702

Non-Operating Income

Foreign exchange gains

Non-Operating Expenses

Ordinary Income
Extraordinary Gain

Total Extraordinary Gain
Extraordinary Losses

Loss on sale of investment securities

Net Income
Loss attributable to non-controlling interests
Net Income Attributable to Owners of Parent

8

HORIBA, Ltd. (Consolidated)

(Consolidated Statements of Comprehensive Income)Amount : Millions of yen
FY2021 Third Quarter(Nine Months Ended
September 30, 2021)

FY2022 Third Quarter(Nine Months Ended
September 30, 2022)

13,71820,6891,205(1,570)(6)-Foreign currency translation adjustments

5,323

16,411Remeasurements of defined benefit plans

36

4

6,559

14,845

20,27835,534

20,27935,544(0)(9)

Net Income
Other Comprehensive Income
Net unrealized holding gains or losses on securities
Deferred gains or losses on hedges

Total Other Comprehensive Income
Comprehensive Income(Breakdown of comprehensive income)Comprehensive income attributable to owners of parent
Comprehensive income attributable to non-controlling interests

9

HORIBA, Ltd. (Consolidated)

(3) Notes to Consolidated Financial Statements
Application of special accounting for preparing quarterly consolidated financial statement(Calculation method for tax expenses)
The Company and its domestic consolidated subsidiaries calculated income tax expenses by multiplying quarterly
income before income taxes by reasonably estimated annual effective tax rate. This tax rate was reasonably
estimated after applying the deferred tax accounting to the annual income before income taxes.
Change in accounting policies(Application of Accounting Standard for Revenue Recognition, etc.)
The Company has applied the “Accounting Standard for Revenue Recognition” (ASBJ Statement No. 29, March
31,2020; hereinafter “Accounting Standard for Revenue Recognition”), etc. from the beginning of the first quarter of
FY2022. Accordingly, revenue is recognized at the time of transfer of control over promised goods or services to thecustomer in the amount expected to be received in return for the goods or services.
The application of the Accounting Standard for Revenue Recognition, etc. is subject to the transitional treatment
provisions in Article 84, but there is no impact on the balance of retained earnings at the beginning of FY2022.
There is no impact on the operating results due to the application of Accounting Standard for Revenue Recognition,etc..
Due to the application of the Accounting Standard for Revenue Recognition, etc., “Trade notes and accounts
receivable” presented under “Current Assets” in the consolidated balance sheets for the previous fiscal year, is
included in “Notes and accounts receivable - trade, and contract assets” instead, and “Advances received” presented
under “Current Liabilities” in the consolidated balance sheets for the previous fiscal year, is included in “Contract
liabilities” instead, from the beginning of the first quarter of FY2022.
In accordance with the transition provisions in Article 89-2 of the Accounting Standard for Revenue Recognition, theCompany has not reclassified financial statements for the previous fiscal year by using the new presentation method.
(Application of “Accounting Standard for Fair Value Measurement,” etc.)
The Company has applied the “Accounting Standard for Fair Value Measurement” (ASBJ Statement No. 30, July 4,
2019; hereinafter “Accounting Standard for Fair Value Measurement”), etc. from the beginning of the first quarter of
FY2022.
The Company has prospectively applied new accounting policies based on the Accounting Standard for Fair Value
Measurement, etc. in accordance with the transition provisions in Article 19 of Accounting Standard for Fair Value
Measurement and Article 44-2 of “Accounting Standard for Financial Instruments” (ASBJ Statement No.10, July 4,2019). There is no impact of these changes on quarterly financial statements.
Additional information(Application of tax effect accounting for transition from consolidated taxation system to group tax sharing
system)With regard to the transition to group tax sharing system established in the “Act for Partial Amendment of the Income
Tax Act, etc.” (Act No. 8 of 2020) and items for which the non-consolidated taxation system has been reviewed in linewith the transition to the group tax sharing system, the Company and its domestic consolidated subsidiaries
calculated the amounts of deferred tax assets and deferred tax liabilities in accordance with the provisions of the tax
act before the amendment based on the treatment of Paragraph 3 of the “Practical Solution on the Treatment of Tax
Effect Accounting for the Transition from the Consolidated Taxation System to the Group Tax Sharing System” (ASBJ
Practical Issues Tax Force No. 39, March 31, 2020), instead of applying the provision of Paragraph 44 of the“Implementation Guidance on Tax Effect Accounting” (ASBJ Guidance No. 28, February 16, 2018).

10

HORIBA, Ltd. (Consolidated)3. Supplemental Information
HORIBA, Ltd. Financial Highlights for the Nine Months Ended September 30, 2022
1. Consolidated Financial Results

Amount : Millions of yen

12/2021
Results

12/2022
Results

3Q (9 Months)

3Q (9 Months)

AmountNet Sales

153,957

185,121

Operating Income

19,859Operating Income Ratio

Ordinary Income

12/2021
Results

12/2022
Forecasts

Ratio

Full year

Full year

AmountRatio+31,164+20.2%

224,314265,000+40,685+18.1%

28,571+8,712+43.9%

32,04643,000+10,953+34.2%

12.9%

15.4%

+2.5P

14.3%

16.2%

+1.9P

32,03843,500+11,461

14.3%

16.4%

+2.1P

21,311

30,000+8,688Changes

Changes

19,86829,508+9,640Ordinary Income Ratio

12.9%

15.9%

+3.0P

Net Income Attributableto Owners of Parent

13,721

20,702+6,980Net Income Ratio

8.9%

11.2%

+2.3P

9.5%

11.3%

+1.8P

US$

108.58128.30+19.72109.90133.00+23.10Euro129.87136.05+6.18

129.91138.00+8.09+48.5%+50.9%

2. Consolidated Segment Results
12/2022
Results

3Q (9 Months)

3Q (9 Months)

Amount

Ratio

Automotive

37,312

41,320+4,008+10.7%

61,249Process&Environmental

14,567

15,425

+857

+5.9%

Medical-Diagnostics

19,122

21,588+2,465

Semiconductor

62,683

81,416

Scientific

20,270Total

Operating Income+40.8%

Amount : Millions of yen

12/2021
Results

Net Sales+35.8%

Changes

12/2021
Results

12/2022
Forecasts

Full year

Full year

ChangesAmountRatio

66,000+4,750+7.8%

20,21723,500+3,282+16.2%+12.9%

25,88228,500+2,617+10.1%+18,732+29.9%

87,004

112,000+24,995+28.7%

25,370+5,100+25.2%

29,95835,000+5,041+16.8%

153,957

185,121+31,164+20.2%

224,314265,000+40,685+18.1%

12/2021
Results

12/2022
Results

3Q (9 Months)

3Q (9 Months)

Amount-(13)

Changes
Ratio

Automotive(1,935)(3,292)-1,357

Process&Environmental

1,294

981

-313

-24.2%

Medical-Diagnostics

84

(21)

-106

Semiconductor

19,722

29,248

Scientific

692

Total

19,85912/2021
Results

12/2022
Forecasts

Full year

Full year

ChangesAmountRatio(1,500)-1,486

-

1,947

2,000

+52

+2.7%

-

148

500

+351

+236.6%+9,526+48.3%

28,00639,500+11,493+41.0%

1,655

+963

+139.1%

1,957

2,500

+542

+27.7%

28,571+8,712+43.9%

32,04643,000+10,953+34.2%

11

HORIBA, Ltd. (Consolidated)3. Consolidated Segment Sales by Destination

Amount : Millions of yen

12/2021
Results

12/2022
Results

3Q (9 Months)

3Q (9 Months)

Amount37,312

41,320+4,008

Japan

10,637

11,170

+533

Asia

9,892

8,093

-1,798Americas

3,863

4,142

+278

+7.2%

Automotive

12/2021
Results

12/2022
Forecasts

Ratio

Full year

Full year+10.7%

61,24966,000+4,750+5.0%

17,365

15,700-1,665-9.6%-18.2%

15,842

14,000-1,842-11.6%

6,475

7,000

+524

+8.1%

Changes

ChangesAmount

Ratio

+7.8%

Europe12,91817,914+4,995+38.7%

21,56629,300+7,733+35.9%

Process&Environmental

14,567

15,425

+857

+5.9%

20,21723,500+3,282+16.2%

Japan

7,328

7,702

+373

+5.1%

10,286

11,000

+713

+6.9%

-0.5%

5,046

6,300

+1,253+24.8%+27.0%

2,281

3,000

+718

+31.5%

Asia

3,795

3,775

-19

Americas

1,656

2,103

+447

Europe

1,787

1,844

+56

+3.2%

2,603

3,200

+596

+22.9%

19,122

21,588+2,465+12.9%

25,88228,500+2,617+10.1%

4,013

4,861

+848

+21.1%

5,243

6,000

+756

+14.4%

Medical-Diagnostics

Japan
Asia

4,192

5,109

+916

+21.9%

5,714

6,500

+785

+13.8%

Americas

4,375

4,670

+294

+6.7%

5,816

6,500

+683

+11.7%

Europe

6,541

6,946

+405

+6.2%

9,108

9,500

+391

+4.3%

Semiconductor

62,683

81,416+18,732+29.9%

87,004

112,000+24,995+28.7%

Japan

19,041

23,801+4,759+25.0%

26,83332,000+5,166+19.3%

Asia

32,327

42,683+10,355+32.0%

44,85760,000+15,142+33.8%

Americas

7,209

10,340+3,130+43.4%

9,813

14,000+4,186+42.7%

Europe

4,103

4,590

+486

+11.9%

5,500

6,000

+499

+9.1%

Scientific

20,27025,370+5,100+25.2%

29,95835,000+5,041+16.8%

Japan

4,859

5,138

+278

+5.7%

6,686

7,500

+813

+12.2%

Asia

4,765

7,954

+3,188+66.9%

8,057

10,300+2,242+27.8%

Americas

6,543

7,808

+1,265+19.3%

8,992

10,500+1,507+16.8%

Europe

4,102

4,469

+367

+9.0%

6,223

6,700

+476

+7.7%

Total

153,957

185,121+31,164+20.2%

224,314265,000+40,685+18.1%

Japan

45,881

52,674+6,792+14.8%

66,414

72,200+5,785

+8.7%

Asia

54,97367,616+12,643+23.0%

79,517

97,100+17,582+22.1%

Americas23,64929,065+5,416+22.9%

33,37941,000+7,620+22.8%

Europe29,45335,764+6,311+21.4%

45,00254,700+9,697+21.5%

12

HORIBA, Ltd. (Consolidated)5. Consolidated Financial Results (Quarterly Comparison)

Amount : Millions of yen

12/2021 Results

Net Sales
Operating Income
Operating Income Ratio

Ordinary Income
Ordinary Income Ratio

Net Income Attributableto Owners of Parent
Net Income Ratio

1Q

2Q

3Q

48,582

52,734

52,639

5,936

7,133

6,789

12.2%

13.5%

12.9%

5,885

7,161

12.1%

13.6%

3,900
8.0%

12/2022
4Q

1Q Results

2Q Results

3Q Results

4Q Forecasts

70,35655,51012,187

8,605

59,45470,15679,878

7,654

12,311

14,428

17.3%

15.5%

12.9%

17.5%

18.1%

6,820
13.0%

12,169

8,743

8,041

12,723

13,991

17.3%

15.8%

13.5%

18.1%

17.5%

4,844

4,976

7,590

5,721

5,518

9,461

9,297

9.2%

9.5%

10.8%

10.3%

9.3%

13.5%

11.6%

6. Consolidated Segment Results (Quarterly Comparison)
Net Sales

Amount : Millions of yen

12/2021 Results

12/2022

1Q

2Q

3Q

4Q

1Q Results

2Q Results

3Q Results

4Q Forecasts

Automotive

12,153

12,77012,38823,937

13,67512,013

15,632

24,679Process&Environmental

5,224

4,816

4,527

5,649

4,788

5,403

5,233

8,074

Medical-Diagnostics

6,302

6,593

6,226

6,759

6,650

7,022

7,914

6,911

Semiconductor

18,441

21,602

22,64024,32122,22527,19531,99430,583

Scientific

6,461

6,951

6,857

9,688

8,169

7,819

9,380

9,629

Total

48,582

52,734

52,63970,35655,51059,45470,15679,878

1Q

2Q

3Q

4Q

1Q Results

2Q Results

3Q Results

4Q Forecasts

(747)

1,921

133

(1,895)(1,530)1,792

Operating Income

12/2021 Results

12/2022

Automotive

(424)

(763)

Process&Environmental

699

414

180

652

453

184

343

1,018

Medical-Diagnostics

164

162

(242)

63

154

(316)

140

521

Semiconductor

5,257

7,093

7,370

8,284

7,180

9,600

12,468

10,251

Scientific

239

224

228

1,265

683

82

890

844

Total

5,936

7,133

6,789

12,187

8,605

7,654

12,311

14,428

Contact
Corporate Planning and Investor Relations, Corporate Planning Office, Finance and Legal Division, HORIBA, Ltd.
2, Miyanohigashi-cho, Kisshoin, Minami-ku, Kyoto 601-8510, Japan
E-mail: ir-info@horiba.com

13

HORIBA, Ltd. (Consolidated)